NASDAQ:CELL - Nasdaq - US0843101017 - Common Stock - Currency: USD
0.9981
+0 (+0.31%)
The current stock price of CELL is 0.9981 USD. In the past month the price increased by 5.06%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
TMO | THERMO FISHER SCIENTIFIC INC | 19.86 | 164.16B | ||
DHR | DANAHER CORP | 27.5 | 146.60B | ||
A | AGILENT TECHNOLOGIES INC | 22.83 | 35.02B | ||
IQV | IQVIA HOLDINGS INC | 14.41 | 28.16B | ||
MTD | METTLER-TOLEDO INTERNATIONAL | 30.25 | 25.43B | ||
WAT | WATERS CORP | 29.63 | 21.00B | ||
WST | WEST PHARMACEUTICAL SERVICES | 34.21 | 16.32B | ||
ILMN | ILLUMINA INC | 29.8 | 15.71B | ||
RVTY | REVVITY INC | 20.59 | 11.96B | ||
ICLR | ICON PLC | 10.97 | 11.96B | ||
QGEN | QIAGEN N.V. | 20.93 | 10.42B | ||
TEM | TEMPUS AI INC | N/A | 9.85B |
PhenomeX, Inc. is a biology company that engages in the study of cells. The company is headquartered in Emeryville, California and currently employs 285 full-time employees. The company went IPO on 2020-07-17. The firm enables scientists to leverage each cell and drive the next generation of functional cell biology that will advance human health. The firm enables scientists to reveal insights into cell function and obtain a full view of the behavior of each cell. Its specific suite of proven tools and services offers unparalleled resolution and speed the insights that are key to advancing discoveries that can completely improve the prevention and treatment of disease. The Company’s platforms are used by researchers across the globe, including various global pharmaceutical companies and approximately 85% of United States cancer centers.
PHENOMEX INC
5858 Horton Street, Suite 320
Emeryville CALIFORNIA US
Employees: 285
Phone: 15108582855.0
The current stock price of CELL is 0.9981 USD. The price increased by 0.31% in the last trading session.
The exchange symbol of PHENOMEX INC is CELL and it is listed on the Nasdaq exchange.
CELL stock is listed on the Nasdaq exchange.
11 analysts have analysed CELL and the average price target is 1.53 USD. This implies a price increase of 53.29% is expected in the next year compared to the current price of 0.9981. Check the PHENOMEX INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
PHENOMEX INC (CELL) has a market capitalization of 98.79M USD. This makes CELL a Micro Cap stock.
PHENOMEX INC (CELL) currently has 285 employees.
PHENOMEX INC (CELL) has a support level at 0.99 and a resistance level at 1.01. Check the full technical report for a detailed analysis of CELL support and resistance levels.
The Revenue of PHENOMEX INC (CELL) is expected to decline by -10.41% in the next year. Check the estimates tab for more information on the CELL EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
CELL does not pay a dividend.
PHENOMEX INC (CELL) will report earnings on 2023-11-06, after the market close.
PHENOMEX INC (CELL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.38).
ChartMill assigns a technical rating of 7 / 10 to CELL.
ChartMill assigns a fundamental rating of 3 / 10 to CELL. While CELL seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months CELL reported a non-GAAP Earnings per Share(EPS) of -1.38. The EPS decreased by -9.52% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -69.85% | ||
ROE | -111.9% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 51% to CELL. The Buy consensus is the average rating of analysts ratings from 11 analysts.
For the next year, analysts expect an EPS growth of 17.97% and a revenue growth -10.41% for CELL